CN Patent

CN113260618A — 二甲氧基苯化合物类似物、分析所述化合物的方法和所述化合物的标准品

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2021-08-13 · 5y expired

What this patent protects

由式(1)至(5)中任一项表示的化合物或其盐、或其组合。式(1)：1,3‑双((S)‑3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)丙‑1‑酮。式(2)：1‑((S)‑3‑(4‑((3‑((S)‑3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)‑3‑氧代丙基)氨基)‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)丙‑2‑烯‑1‑酮。式(3)：(S)‑3‑((1‑(1‑丙烯酰基吡…

USPTO Abstract

由式(1)至(5)中任一项表示的化合物或其盐、或其组合。式(1)：1,3‑双((S)‑3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)丙‑1‑酮。式(2)：1‑((S)‑3‑(4‑((3‑((S)‑3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)‑3‑氧代丙基)氨基)‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)丙‑2‑烯‑1‑酮。式(3)：(S)‑3‑((1‑(1‑丙烯酰基吡咯烷‑3‑基)‑6‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑4‑基)氨基)丙酸。式(4)：(S)‑3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑甲醛。式(5)：(S)‑1‑(3‑(4‑氨基‑3‑((3,5‑二甲氧基苯基)乙炔基)‑1H‑吡唑并[3,4‑d]嘧啶‑1‑基)吡咯烷‑1‑基)‑3‑羟丙‑1‑酮。

Drugs covered by this patent

Patent Metadata

Patent number
CN113260618A
Jurisdiction
CN
Classification
—
Expires
2021-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Taiho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.